You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 10,669,546


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,669,546 protect, and when does it expire?

Patent 10,669,546 protects QALSODY and is included in one NDA.

This patent has sixty patent family members in twenty-six countries.

Summary for Patent: 10,669,546
Title:Compositions for modulating SOD-1 expression
Abstract:Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).
Inventor(s):Swayze Eric E.
Assignee:Biogen MA Inc.
Application Number:US16513297
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 10,669,546

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biogen Ma QALSODY tofersen SOLUTION;INTRATHECAL 215887-001 Apr 25, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) IN ADULTS WHO HAVE A MUTATION IN THE SUPEROXIDE DISMUTASE 1 (SOD1) GENE ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,669,546

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3126499 ⤷  Sign Up CR 2024 00038 Denmark ⤷  Sign Up
European Patent Office 3126499 ⤷  Sign Up 301293 Netherlands ⤷  Sign Up
Australia 2015240761 ⤷  Sign Up
Australia 2019268063 ⤷  Sign Up
Australia 2022200002 ⤷  Sign Up
Australia 2024202423 ⤷  Sign Up
Brazil 112016021848 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.